3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
7
Pain
5
Prostatic Neoplasms
2
Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Vomiting
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Seminoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain, Postoperative
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nausea
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Bupivacaine
8
Control Groups
6
Saline Solution
5
Ropivacaine
5
Ketamine
5
Sodium Chloride
4
Lidocaine
4
Dexmedetomidine
4
Anesthetics, Local
4
Morphine
3
Anti-Inflammatory Agents, Non-Steroidal
3
Diazepam
2
Botulinum Toxins, Type A
2
Analgesics, Opioid
2
Acetaminophen
2
thiamine triphosphorate
1
oxycodone-acetaminophen
1
esmolol
1
Vitamins
1
Tramadol
1
Therapeutics
1
Surgical Procedures, Operative
1
Sufentanil
1
Nerve Block
1
Narcotics
1
Nalbuphine
1
Mindfulness
1
Mastectomy, Segmental
1
Mammaplasty
1
Magnesium Sulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Postoperative
×
Analgesia
×
Breast
×
Clear all
NCT05876390
2026-04-16
IRACPoP
Niguarda Hospital
Enrolling by invitation
1,500 enrolled